Nancy Santesso1, Claire Glenton2, Philipp Dahm3, Paul Garner4, Elie A Akl5, Brian Alper6, Romina Brignardello-Petersen7, Alonso Carrasco-Labra7, Hans De Beer8, Monica Hultcrantz9, Ton Kuijpers10, Joerg Meerpohl11, Rebecca Morgan7, Reem Mustafa12, Nicole Skoetz13, Shahnaz Sultan14, Charles Wiysonge15, Gordon Guyatt16, Holger J Schünemann16. 1. Department of Health Research Methods, Evidence and Impact, Cochrane Canada, MacGRADE Centre and Michael G. DeGroote Cochrane Canada Centre, McMaster University, 1280 Main St East, Hamilton, L8S 4L8, Canada. Electronic address: santesna@mcmaster.ca. 2. Cochrane Norway and the Informed Health Choices Research Centre, Norwegian Institute of Public Health, Postboks 222 Skøyen, Sandakerveien 24C, inngang D11, 0213, Oslo, Norway. 3. Minneapolis VA Health Care System, Urology Section 112D, One Veterans Drive, Minneapolis, MN, 55417, USA. 4. Centre for Evidence Synthesis in Global Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. 5. Department of Internal Medicine, American University of Beirut, P.O.Box 11-0236, Lebanon. 6. EBSCO Health, Innovations and Evidence-Based Medicine Development, 10 Estes Street, Ipswich, MA, 01938, USA; Department of Family and Community Medicine, University of Missouri-Columbia, Columbia, MO, USA. 7. Department of Health Research Methods, Evidence and Impact, Cochrane Canada, MacGRADE Centre and Michael G. DeGroote Cochrane Canada Centre, McMaster University, 1280 Main St East, Hamilton, L8S 4L8, Canada. 8. Guide2Guidance, Lemelerberg 7, 3524 LC Utrecht, the Netherlands. 9. Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), S:t Eriksgatan 117, SE-102 33, Stockholm, Sweden. 10. Department of Guideline Development and Research, Dutch College of General Practitioners (NHG), Mercatorlaan 1200, 3528, BL, Utrecht, the Netherlands. 11. Institute for Evidence in Medicine, Breisacher Strasse 153, 79110, Freiburg, Germany. 12. Department of Health Research Methods, Evidence and Impact, Cochrane Canada, MacGRADE Centre and Michael G. DeGroote Cochrane Canada Centre, McMaster University, 1280 Main St East, Hamilton, L8S 4L8, Canada; Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, MS3002, Kansas City, KS, 66160, USA. 13. Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne, Kerpener Str. 62, 50931, Cologne, Germany. 14. Division of Gastroenterology and Hepatology, and Nutrition, University of Minnesota, Minneapolis Veterans Affairs Healthcare System, 516 Delaware St. SE, 1st Floor, Phillips-Wangsteen Building, MMC 36, Minneapolis, MN, 55455, USA. 15. Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; Department of Global Health, Stellenbosch University, Cape Town, South Africa; Cochrane South Africa, South African Medical Research Council, Francie van Zijl Drive, Parow Valley, 7501, Cape Town, South Africa. 16. Department of Health Research Methods, Evidence and Impact, Cochrane Canada, MacGRADE Centre and Michael G. DeGroote Cochrane Canada Centre, McMaster University, 1280 Main St East, Hamilton, L8S 4L8, Canada; Department of Medicine, McMaster University, 1280, Main St East, L8S 4L8, Hamilton, Canada.
Abstract
OBJECTIVES: Clear communication of systematic review findings will help readers and decision makers. We built on previous work to develop an approach that improves the clarity of statements to convey findings and that draws on Grading of Recommendations Assessment, Development and Evaluation (GRADE). STUDY DESIGN AND SETTING: We conducted workshops including 80 attendants and a survey of 110 producers and users of systematic reviews. We calculated acceptability of statements and revised the wording of those that were unacceptable to ≥40% of participants. RESULTS: Most participants agreed statements should be based on size of effect and certainty of evidence. Statements for low, moderate and high certainty evidence were acceptable to >60%. Key guidance, for example, includes statements for high, moderate and low certainty for a large effect on intervention x as: x results in a large reduction…; x likely results in a large reduction…; x may result in a large reduction…, respectively. CONCLUSIONS: Producers and users of systematic reviews found statements to communicate findings combining size and certainty of an effect acceptable. This article provides GRADE guidance and a wording template to formulate statements in systematic reviews and other decision tools.
OBJECTIVES: Clear communication of systematic review findings will help readers and decision makers. We built on previous work to develop an approach that improves the clarity of statements to convey findings and that draws on Grading of Recommendations Assessment, Development and Evaluation (GRADE). STUDY DESIGN AND SETTING: We conducted workshops including 80 attendants and a survey of 110 producers and users of systematic reviews. We calculated acceptability of statements and revised the wording of those that were unacceptable to ≥40% of participants. RESULTS: Most participants agreed statements should be based on size of effect and certainty of evidence. Statements for low, moderate and high certainty evidence were acceptable to >60%. Key guidance, for example, includes statements for high, moderate and low certainty for a large effect on intervention x as: x results in a large reduction…; x likely results in a large reduction…; x may result in a large reduction…, respectively. CONCLUSIONS: Producers and users of systematic reviews found statements to communicate findings combining size and certainty of an effect acceptable. This article provides GRADE guidance and a wording template to formulate statements in systematic reviews and other decision tools.
Authors: Laura Moschino; Viraraghavan Vadakkencherry Ramaswamy; Irwin Karl Marcel Reiss; Eugenio Baraldi; Charles Christoph Roehr; Sinno Henricus Paulus Simons Journal: Pediatr Res Date: 2022-06-02 Impact factor: 3.756
Authors: Stefan K Plontke; Christoph Meisner; Sumit Agrawal; Per Cayé-Thomasen; Kevin Galbraith; Anthony A Mikulec; Lorne Parnes; Yaamini Premakumar; Julia Reiber; Anne Gm Schilder; Arne Liebau Journal: Cochrane Database Syst Rev Date: 2022-07-22
Authors: Dena Zeraatkar; Arrti Bhasin; Rita E Morassut; Isabella Churchill; Arnav Gupta; Daeria O Lawson; Anna Miroshnychenko; Emily Sirotich; Komal Aryal; David Mikhail; Tauseef A Khan; Vanessa Ha; John L Sievenpiper; Steven E Hanna; Joseph Beyene; Russell J de Souza Journal: Am J Clin Nutr Date: 2021-06-01 Impact factor: 7.045
Authors: Zhikang Ye; Ying Wang; Long Ge; Gordon H Guyatt; David Collister; Waleed Alhazzani; Sean M Bagshaw; Emilie P Belley-Cote; Fang Fang; Liangying Hou; Philipp Kolb; Francois Lamontagne; Simon Oczkowski; Lonnie Pyne; Christian Rabbat; Matt Scaum; Borna Tadayon Najafabadi; Wimonchat Tangamornsuksan; Ron Wald; Qi Wang; Michael Walsh; Liang Yao; Linan Zeng; Abdullah Mohammed Algarni; Rachel J Couban; Paul Elias Alexander; Bram Rochwerg Journal: Crit Care Explor Date: 2021-05-12
Authors: Makinna C Oestreich; Robin Wm Vernooij; Niranjan J Sathianathen; Eu Chang Hwang; Gretchen M Kuntz; Alex Koziarz; Charles D Scales; Philipp Dahm Journal: Cochrane Database Syst Rev Date: 2020-11-12